Status:

COMPLETED

B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites

Lead Sponsor:

University of Sao Paulo

Collaborating Sponsors:

University of Sao Paulo General Hospital

Conditions:

Heart Failure

Liver Cirrhosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The serum albumin ascites gradient (SAAG) is a recommended tool for ascites diagnosis since values ≥1.1 g/dl are found in nearly 97% of patients with portal hypertension. However, it mislabels chronic...

Detailed Description

Diagnostic criteria for the cause of ascites - two independent cardiologists and two hepatologists will interview and examine the enrolled patients and review the clinical records, laboratory and imag...

Eligibility Criteria

Inclusion

  • more than 18 years old.
  • must have signed the written informed consent.
  • ascites of any etiology on clinical and laboratory imaging.
  • fulfil stringent diagnostic criteria for the cause of the ascites.

Exclusion

  • contra-indication for paracentesis (hemodynamic instability, shock, active variceal bleeding etc).
  • sepsis.
  • fulminant liver failure.
  • pregnancy.
  • history of recent transfusion of blood components and/or derivates or volume expansion.

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2012

Estimated Enrollment :

278 Patients enrolled

Trial Details

Trial ID

NCT01150916

Start Date

June 1 2010

End Date

March 1 2012

Last Update

December 20 2012

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Federal University of Espirito Santo

Vitória, Espírito Santo, Brazil, 29045-402

2

Hospital das Clinicas. University of São Paulo

São Paulo, São Paulo, Brazil, 05403-000